Our expertise spans dermatology and skin care, aesthetic medicine and medical devices, healthcare technology, diagnostics and responsible AI, and the transformation of clinics and care models.
Across these fields, theSKINBOX helps healthcare and industry leaders assess opportunities, close evidence gaps and determine what it will take to move from scientific or technological promise to credible implementation.
Make better decisions about skin-care products, claims and innovation.
We support dermatology, dermocosmetic and skin-care organisations in evaluating scientific evidence, identifying unmet needs and translating skin biology into relevant product and portfolio strategies. Our expertise includes the skin barrier, sensitive and eczema-prone skin, wound healing, scars, skin ageing and functional skin longevity.
From evidence reviews and clinical evaluation to product concepts, claims strategy and post-market research, we help determine what is scientifically credible, clinically relevant and commercially distinctive.
Build evidence and strategies that support responsible clinical adoption.
We advise medical-device and aesthetic-medicine companies working with injectables, energy-based devices, tissue-management technologies, post-procedure care and combination treatment strategies. We assess clinical relevance, evidence gaps, adoption barriers and professional education requirements across the product lifecycle.
Our work can include clinical and post-market evidence programmes, expert engagement, risk and aftercare frameworks, launch strategy and the translation of evidence into credible communication for healthcare professionals.
Separate technological promise from clinically and commercially relevant value.
We help digital-health, diagnostic, biomarker, bioprinting, beauty-technology and AI innovators evaluate potential applications, evidence requirements and implementation barriers. Our assessments connect the proposed technology with real clinical needs, available data, professional workflows, human oversight and market conditions.
The objective is not simply to validate whether a technology can work, but to determine where it creates meaningful value, what evidence is still missing and what would be required for credible adoption.
Turn clinical expertise, services and technology investments into a coherent care model.
We work with clinics, specialist practices and emerging care providers on service design, clinical and patient pathways, treatment portfolio strategy, technology selection, team development, professional education and operating models.
By connecting patient relevance, clinical quality and commercial viability, we help organisations decide which services to offer, how to deliver them and what capabilities are required to implement and scale them responsibly.
theSKINBOX works with organisations making consequential decisions about healthcare evidence, innovation, products and models of care.
We support product evaluation, evidence generation, portfolio strategy, market access, clinical adoption and transformation programmes.
We help develop differentiated services, patient pathways, technology portfolios, education programmes and sustainable operating models.
We provide independent intelligence on scientific maturity, clinical relevance, implementation requirements, market positioning and commercial potential.
We contribute evidence frameworks, independent analysis, professional education and cross-sector initiatives designed to strengthen healthcare decisions.
theSKINBOX is developing an AI-enabled intelligence framework to make complex healthcare evidence easier to compare, interpret and use.
The concept is designed to connect information from scientific research, clinical evidence, regulatory sources, professional practice and relevant market signals. It will help users compare products, active ingredients, technologies and alternatives, identify evidence gaps and emerging signals, and explore how a field or innovation may develop.
Every insight is intended to remain traceable to its sources and open to expert review. The system will support informed human decisions. It does not provide automated clinical recommendations, replace regulatory assessment or act as a substitute for professional guidelines and accountability.
We are currently defining priority applications with selected healthcare and institutional partners.